Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-06-14 @ 6:07 AM
Study NCT ID:
NCT05234320
Status:
UNKNOWN
Last Update Posted:
2022-09-22
First Post:
2022-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug
Sponsor:
Caregen Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: